Signaling Pathways - Aldosterone receptor - Voltage-gated Sodium (NaV) Channels - PARs - Animal Experiments
清除全部
-
B6801 SCH 79797 dihydrochlorideTarget: PARsSummary: PAR1受体拮抗剂 -
B7590 Quinidine中文名: 奎尼丁Target: Voltage-gated Sodium (NaV) Channels|Cytochrome P450 (CYP450)Summary: 降低Na+和K+通道电流 -
B1420 Bupivacaine HCl中文名: 盐酸布比卡因Target: Voltage-gated Sodium (NaV) ChannelsSummary: 麻醉药 -
B2272 Phenytoin sodium中文名: 苯妥英钠Target: Voltage-gated Sodium (NaV) ChannelsSummary: 钠通道稳定剂 -
B2274 Proparacaine HCl中文名: 盐酸丙美卡因Target: Voltage-gated Sodium (NaV) ChannelsSummary: 电压门控钠通道拮抗剂 -
B2277 A-803467Target: Voltage-gated Sodium (NaV) ChannelsSummary: NaV1.8通道阻断剂 -
A8513 Riluzole中文名: 力鲁唑Target: Voltage-gated Sodium (NaV) Channels|glutamate releaseSummary: 钠通道抑制剂 -
A8506 Potassium CanrenoateTarget: Aldosterone receptorSummary: 醛固酮拮抗剂 -
A5354 Zonisamide中文名: 唑尼沙胺Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) ChannelsSummary: 抗惊厥和机械效应的抗癫痫药 -
A3418 Flecainide acetate中文名: 氟卡胺Target: Voltage-gated Sodium (NaV) ChannelsSummary: 抗心律失常药